Synthesis and structure based optimization of novel Akt inhibitors.

Akt1 X-ray co-crystal structures are utilized to optimize the potency of an HTS hit to a spiroindoline pyrrolopyrimidine. The synthesis and SAR of multiple inhibitor classes, along with the efficacy of one lead compound in a tumor model are presented.